Cargando…
Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544388/ https://www.ncbi.nlm.nih.gov/pubmed/35857756 http://dx.doi.org/10.1111/bjh.18372 |
| _version_ | 1784804585875963904 |
|---|---|
| author | van der Sluis, Inge M. Bertrand, Yves Baruchel, André Pieters, Rob |
| author_facet | van der Sluis, Inge M. Bertrand, Yves Baruchel, André Pieters, Rob |
| author_sort | van der Sluis, Inge M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9544388 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95443882022-10-14 Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? van der Sluis, Inge M. Bertrand, Yves Baruchel, André Pieters, Rob Br J Haematol Letters to the Editor–Online Only John Wiley and Sons Inc. 2022-07-20 2022-09 /pmc/articles/PMC9544388/ /pubmed/35857756 http://dx.doi.org/10.1111/bjh.18372 Text en © 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor–Online Only van der Sluis, Inge M. Bertrand, Yves Baruchel, André Pieters, Rob Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title | Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title_full | Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title_fullStr | Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title_full_unstemmed | Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title_short | Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| title_sort | is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia? |
| topic | Letters to the Editor–Online Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544388/ https://www.ncbi.nlm.nih.gov/pubmed/35857756 http://dx.doi.org/10.1111/bjh.18372 |
| work_keys_str_mv | AT vandersluisingem isasparaginaseencapsulatedinerythrocyteseffectiveassecondlinetreatmentinacutelymphoblasticleukaemia AT bertrandyves isasparaginaseencapsulatedinerythrocyteseffectiveassecondlinetreatmentinacutelymphoblasticleukaemia AT baruchelandre isasparaginaseencapsulatedinerythrocyteseffectiveassecondlinetreatmentinacutelymphoblasticleukaemia AT pietersrob isasparaginaseencapsulatedinerythrocyteseffectiveassecondlinetreatmentinacutelymphoblasticleukaemia |